The Cerbat Gem logo

The Latest Headlines at The Cerbat Gem

Image about Brokerages Set Hannover Rück SE (OTCMKTS:HVRRY) Target Price at $183.67

Brokerages Set Hannover Rück SE (OTCMKTS:HVRRY) Target Price at $183.67

Shares of Hannover Rück SE (OTCMKTS:HVRRY – Get Rating) have received a consensus recommendation of “Hold” from the eight research firms that are covering the firm, Marketbeat Ratings reports. One analyst has rated... More of this article »
Image about Analyzing eGain (NASDAQ:EGAN) & Zenvia (NASDAQ:ZENV)

Analyzing eGain (NASDAQ:EGAN) & Zenvia (NASDAQ:ZENV)

eGain (NASDAQ:EGAN – Get Rating) and Zenvia (NASDAQ:ZENV – Get Rating) are both small-cap computer and technology companies, but which is the better business? We will compare the two businesses based on the strength of... More of this article »
Image about Head to Head Analysis: SI-BONE (NASDAQ:SIBN) & Invo Bioscience (OTCMKTS:IVOB)

Head to Head Analysis: SI-BONE (NASDAQ:SIBN) & Invo Bioscience (OTCMKTS:IVOB)

SI-BONE (NASDAQ:SIBN – Get Rating) and Invo Bioscience (OTCMKTS:IVOB – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends,... More of this article »
Image about Close Brothers Group plc (LON:CBG) Given Average Rating of “Moderate Buy” by Brokerages

Close Brothers Group plc (LON:CBG) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Close Brothers Group plc (LON:CBG – Get Rating) have earned a consensus recommendation of “Moderate Buy” from the six brokerages that are currently covering the stock, MarketBeat Ratings reports. One investment... More of this article »
Image about Synovus Financial (NYSE:SNV) PT Lowered to $35.00 at Truist Financial

Synovus Financial (NYSE:SNV) PT Lowered to $35.00 at Truist Financial

Synovus Financial (NYSE:SNV – Get Rating) had its price objective decreased by Truist Financial from $48.00 to $35.00 in a research report released on Thursday, The Fly reports. A number of other equities analysts also recently... More of this article »
Image about Allstate (NYSE:ALL) PT Lowered to $132.00 at Evercore ISI

Allstate (NYSE:ALL) PT Lowered to $132.00 at Evercore ISI

Allstate (NYSE:ALL – Get Rating) had its target price cut by Evercore ISI from $138.00 to $132.00 in a research note published on Thursday, The Fly reports. They currently have an in-line rating on the insurance provider’s... More of this article »
Image about GigaCloud Technology (GCT) versus Its Competitors Financial Comparison

GigaCloud Technology (GCT) versus Its Competitors Financial Comparison

GigaCloud Technology (NASDAQ:GCT – Get Rating) is one of 54 publicly-traded companies in the “Catalog & mail – order houses” industry, but how does it contrast to its peers? We will compare GigaCloud Technology... More of this article »
Image about Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $862.00

Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $862.00

Regeneron Pharmaceuticals (NASDAQ:REGN – Get Rating) had its price objective hoisted by EF Hutton Acquisition Co. I from $853.00 to $862.00 in a report issued on Thursday, Benzinga reports. They currently have a buy rating on... More of this article »
Image about Live Oak Bancshares (NASDAQ:LOB) PT Lowered to $29.00 at Truist Financial

Live Oak Bancshares (NASDAQ:LOB) PT Lowered to $29.00 at Truist Financial

Live Oak Bancshares (NASDAQ:LOB – Get Rating) had its price target decreased by Truist Financial from $37.00 to $29.00 in a research report report published on Thursday, The Fly reports. Truist Financial currently has a buy rating... More of this article »
Image about HC Wainwright Trims Werewolf Therapeutics (NASDAQ:HOWL) Target Price to $15.00

HC Wainwright Trims Werewolf Therapeutics (NASDAQ:HOWL) Target Price to $15.00

Werewolf Therapeutics (NASDAQ:HOWL – Get Rating) had its target price reduced by HC Wainwright from $20.00 to $15.00 in a research note released on Thursday morning, The Fly reports. They currently have a buy rating on the stock. Separately,... More of this article »
Image about Nektar Therapeutics (NASDAQ:NKTR) Receives Consensus Recommendation of “Hold” from Brokerages

Nektar Therapeutics (NASDAQ:NKTR) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Nektar Therapeutics (NASDAQ:NKTR – Get Rating) have been given an average rating of “Hold” by the eight ratings firms that are covering the stock, MarketBeat Ratings reports. Three investment analysts have... More of this article »
Image about Almaden Minerals (NYSEAMERICAN:AAU) Research Coverage Started at StockNews.com

Almaden Minerals (NYSEAMERICAN:AAU) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Almaden Minerals (NYSEAMERICAN:AAU – Get Rating) (TSE:AMM) in a research report sent to investors on Thursday. The brokerage issued a sell rating on the basic materials company’s... More of this article »
Image about StockNews.com Upgrades Ryder System (NYSE:R) to Strong-Buy

StockNews.com Upgrades Ryder System (NYSE:R) to Strong-Buy

StockNews.com upgraded shares of Ryder System (NYSE:R – Get Rating) from a buy rating to a strong-buy rating in a research note published on Thursday. Other research analysts have also issued reports about the stock. Wolfe Research... More of this article »
Image about Check-Cap (NASDAQ:CHEK) Coverage Initiated at StockNews.com

Check-Cap (NASDAQ:CHEK) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Check-Cap (NASDAQ:CHEK – Get Rating) in a research note issued to investors on Thursday. The firm issued a sell rating on the medical research company’s stock. Check-Cap Trading... More of this article »
Image about National Beverage (NASDAQ:FIZZ) Upgraded to “Buy” at StockNews.com

National Beverage (NASDAQ:FIZZ) Upgraded to “Buy” at StockNews.com

StockNews.com upgraded shares of National Beverage (NASDAQ:FIZZ – Get Rating) from a hold rating to a buy rating in a research note published on Thursday. Separately, Jefferies Financial Group downgraded National Beverage from... More of this article »